1. International Agency for Research on Cancer (2008) GLOBOCAN. Available from: http://globocan.iarc.fr . Accessed 5 May 2013
2. Davey DD, Neal MH, Wilbur DC, Colgan TJ, Styer PE, Mody DR (2004) Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med 128:1224–1229
3. Eversole GM, Moriarty AT, Schwartz MR, Clayton AC, Souers R, Fatheree LA et al (2010) Practices of participants in the College of American Pathologists interlaboratory comparison program in cervicovaginal cytology, 2006. Arch Pathol Lab Med 134:331–335
4. Eltoum IA, Roberson J (2007) Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS). Cancer 111:34–40
5. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197:346–355